Dysmenorrhoea — painful menstruation — is among the most common conditions of adolescence and among the least medically addressed.
Prevalence estimates vary with definition, but studies consistently find that a majority of menstruating adolescents experience some pain and that a substantial minority experience pain severe enough to limit normal activity.
The absence data
The clearest evidence that this is a significant problem rather than a minor inconvenience comes from school absence figures.
Studies across many countries have found that a meaningful proportion of adolescents report missing school because of menstrual pain, with figures commonly in the range of a fifth to a third of respondents reporting at least occasional absence.
Reported reductions in concentration and participation while present are higher still.
Whatever the exact figures, the direction is unambiguous: this is one of the more common causes of adolescent educational disruption, and it is largely invisible in absence records because it is not usually recorded as a medical cause.
The normalisation problem
The most frequently identified barrier to treatment in qualitative research is the belief that severe pain is normal and must be tolerated.
This belief is held by patients, frequently by their families, and sometimes by clinicians. It has a superficial basis — some discomfort is common — and it produces a systematic failure to distinguish between common discomfort and pain that warrants investigation.
Studies asking adolescents about help-seeking find that a large proportion of those with severe symptoms have never sought medical advice, and that the most common reason given is the assumption that nothing can be done.
That assumption is incorrect, which is what makes the normalisation costly rather than merely unfortunate.
Primary versus secondary
The clinically important distinction is between pain with no identifiable underlying pathology and pain caused by an underlying condition — most commonly endometriosis, but also fibroids, adenomyosis and structural anomalies.
The distinction matters because the second category requires diagnosis and specific treatment, and because delayed diagnosis of endometriosis is a well-documented problem with average delays measured in years across multiple national studies.
Features that should prompt further investigation include pain that does not respond to standard treatment, pain occurring outside menstruation, pain that worsens progressively over time, pain with bowel or bladder symptoms, and pain associated with heavy bleeding.
None of these guarantees an underlying condition. All of them are reasons to investigate rather than to manage symptomatically and stop.
Treatments with evidence
Non-steroidal anti-inflammatory drugs. The evidence base here is strong. These work by inhibiting prostaglandin production, which is the mechanism generating the pain, and reviews consistently find them effective for the majority of users.
Two practical points are frequently missed. Timing matters — starting before or at symptom onset rather than after pain is established substantially improves effect. And adequate dosing matters; many people take sub-therapeutic doses.
Hormonal contraception. Combined hormonal contraception and progestogen-only methods both have reasonable evidence for reducing dysmenorrhoea, and several are licensed for this indication independently of contraceptive need. This is not always made clear to patients.
Heat. Topical heat has been studied and found comparably effective to some analgesia in several trials. It is cheap, has no side effects, and is a legitimate first-line option rather than a folk remedy.
Exercise. Reviews find modest evidence of benefit, though study quality is variable.
Many supplements have been studied with generally weak or inconsistent results. The commercial claims in this area substantially exceed the evidence.
The heavy bleeding question
Heavy menstrual bleeding frequently accompanies severe pain and has consequences beyond the immediate.
Iron deficiency is the main one. It is common in menstruating adolescents, it is frequently undiagnosed, and its effects — fatigue, reduced concentration, reduced exercise capacity — are easy to attribute to adolescence generally.
The test is simple and cheap. Ferritin, rather than haemoglobin alone, is the relevant measure, because iron stores are depleted well before anaemia appears.
Anyone with heavy bleeding, fatigue and reduced performance should have iron status checked, and frequently has not.
The school dimension
Institutional arrangements affect this more than they should.
Policies restricting toilet access during lessons, prohibiting carrying analgesia, requiring explanation for absence, and providing no private facilities all raise the cost of managing symptoms at school.
Schools that have addressed these — free product provision, unrestricted toilet access, permitting self-medication with appropriate consent, private facilities — report improvements in attendance and participation.
These are policy decisions rather than resource-intensive ones, and their absence is generally a matter of nobody having considered the question rather than a considered position.
The sentence worth keeping
Pain that stops you doing normal things is not normal, regardless of how common it is. Commonality and normality are different claims, and conflating them has left a large number of people managing a treatable condition on the assumption that there was nothing to treat.